{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:51:51Z","timestamp":1793213511036,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients with type 2 diabetes mellitus (T2DM). This study aimed to investigate the prevalence of NAFLD among Saudi patients with T2DM using transient elastography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 490 patients with T2DM who attended diabetes and primary care clinics were recruited. Controlled attenuation parameter (CAP) and liver stiffness measurements (LSM) were obtained via FibroScan to assess steatosis and fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the examined 490 patients with T2DM, 396 (80.8%) had hepatic steatosis (CAP \u2265248 dB\/m): 326 (66.5%) had severe steatosis (CAP \u2265280 dB\/m), while 41 (8.4%) and 29 (5.9%) had mild (CAP \u2265248 to &lt;268 dB\/m) and moderate steatosis (CAP \u2265268 to &lt;280 dB\/m), respectively. Of the 396 patients with steatosis, only 35 (8.8%) had LSM \u22657.9 kPa, suggesting the presence of fibrosis, while 361 (91%) had LSM &lt;7.9 kPa, indicating the absence of fibrosis. Increased body mass index (BMI), waist circumference, systolic blood pressure (SBP), and alanine aminotransferase (ALT) were positively associated with both steatosis and fibrosis. After adjusting for age and gender, data from logistic regression analysis demonstrated BMI, waist circumference, SBP, ALT, and high-density lipoprotein (HDL) as significant independent factors for steatosis, while SBP was the only significant predictor associated with fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our results demonstrate an increase in prevalence of NAFLD in Saudi patients with T2DM, based on transient elastography and CAP score. The risk of NAFLD appears to be higher in T2DM patients with abdominal obesity, elevated SBP, and increased ALT levels, which supports the screening of these conditions in patients with T2DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjg.sjg_73_22","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T03:14:48Z","timestamp":1653275688000},"page":"426-433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes"],"prefix":"10.4103","volume":"28","author":[{"given":"Assim A.","family":"Alfadda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphia M.","family":"Sherbeeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel N.","family":"Alqutub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah S.","family":"Aldosary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser M.","family":"Aldaghri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"Taylor-Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukhsana","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman M.","family":"Almaghamsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20240829","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R2-5-20240829","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: The state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"R3-5-20240829","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/tgh.2019.10.02","article-title":"Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: Spectrum and diagnosis","volume":"5","author":"Sharma","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"R4-5-20240829","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: From obesity to metabolic syndrome and diabetes","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"R5-5-20240829","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R6-5-20240829","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cld.2017.08.003","article-title":"The natural history of nonalcoholic fatty liver disease-an evolving view","volume":"22","author":"Lindenmeyer","year":"2018","journal-title":"Clin Liver Dis"},{"key":"R7-5-20240829","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: An expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J Hepatol"},{"key":"R8-5-20240829","first-page":"131","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: Epidemiology, pathogenesis, and prevention","volume":"1","author":"Baffy","year":"2013","journal-title":"J Clin Transl Hepatol"},{"key":"R9-5-20240829","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0256-4947.75773","article-title":"Prevalence of diabetes mellitus in a Saudi community","volume":"31","author":"Alqurashi","year":"2011","journal-title":"Ann Saudi Med"},{"key":"R10-5-20240829","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/sjg.SJG_122_18","article-title":"Nonalcoholic fatty liver disease burden-Saudi Arabia and United Arab Emirates, 2017-30","volume":"24","author":"Alswat","year":"2018","journal-title":"Saudi J Gastroenterol"},{"key":"R11-5-20240829","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1016\/j.sjbs.2021.05.063","article-title":"Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: A retrospective study","volume":"28","author":"Alamri","year":"2021","journal-title":"Saudi J Biol Sci"},{"key":"R12-5-20240829","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"R13-5-20240829","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0028-1091983","article-title":"Diagnosis of nonalcoholic fatty liver disease: Invasive versus noninvasive","volume":"28","author":"Wieckowska","year":"2008","journal-title":"Semin Liver Dis"},{"key":"R14-5-20240829","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"R15-5-20240829","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28394","article-title":"Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy","volume":"63","author":"Cassinotto","year":"2016","journal-title":"Hepatology"},{"key":"R16-5-20240829","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/liv.14274","article-title":"Liver fibrosis by FibroScan (\u00ae) independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes","volume":"40","author":"Lombardi","year":"2020","journal-title":"Liver Int"},{"key":"R17-5-20240829","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5152\/tjg.2018.18559","article-title":"Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study","volume":"30","author":"Demir","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"R18-5-20240829","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: A prospective cohort study","volume":"65","author":"Kwok","year":"2016","journal-title":"Gut"},{"key":"R19-5-20240829","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/jgh.14577","article-title":"Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography","volume":"34","author":"Lai","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"R20-5-20240829","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4183\/aeb.2018.394","article-title":"Non-invasive assessment of liver steatosis and fibrosis using transient elastography and controlled attenuation parameter in type 2 diabetes patients","volume":"14","author":"Sima","year":"2018","journal-title":"Acta Endocrinol (Buchar"},{"key":"R21-5-20240829","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"R22-5-20240829","first-page":"722","article-title":"Prevalence and future prediction of type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A systematic review of published studies","volume":"66","author":"Meo","year":"2016","journal-title":"J Pak Med Assoc"},{"key":"R23-5-20240829","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jegh.2017.10.001","article-title":"Incidence and prevalence rates of diabetes mellitus in Saudi Arabia: An overview","volume":"7","author":"Alotaibi","year":"2017","journal-title":"J Epidemiol Glob Health"},{"key":"R24-5-20240829","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40842-020-00097-1","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: Where do Diabetologists stand?","volume":"6","author":"Tomah","year":"2020","journal-title":"Clin Diabetes Endocrinol"},{"key":"R25-5-20240829","doi-asserted-by":"crossref","first-page":"872","DOI":"10.9734\/BJMMR\/2015\/13077","article-title":"Nonalcoholic fatty liver disease (NAFLD) in Saudi patients with T2DM in Jazan region: Prevalence and associated factors","volume":"5","author":"Elmakki","year":"2014","journal-title":"Br J Med Med Res"},{"key":"R26-5-20240829","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1542-3565(04)00014-X","article-title":"Nonalcoholic fatty liver disease in patients with type 2 diabetes","volume":"2","author":"Younossi","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R27-5-20240829","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"R28-5-20240829","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3748\/wjg.v21.i5.1650","article-title":"Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index","volume":"21","author":"Pang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R29-5-20240829","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"R30-5-20240829","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/liv.13481","article-title":"Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan","volume":"37","author":"Roulot","year":"2017","journal-title":"Liver Int"},{"key":"R31-5-20240829","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-5-20240829","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3748\/wjg.15.1863","article-title":"Non-alcoholic steatohepatitis with normal aminotransferase values","volume":"15","author":"Uslusoy","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R33-5-20240829","first-page":"721","article-title":"High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients","volume":"15","author":"Arab","year":"2016","journal-title":"Ann Hepatol"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_73_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:55:52Z","timestamp":1787756152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_73_22"}},"subtitle":["Evidence from the CORDIAL cohort study"],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_73_22","relation":{},"ISSN":["1319-3767"],"issn-type":[{"value":"1319-3767","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}